摘要
目的: 目前已证实,蛋白质的去甲酰化作用是通过调节多种转录因子调控眼部发育的重要调控机制。然而,利用现有的体外系统,仍需进一步探讨每一个被调控因子的功能机制。在这方面,各种眼细胞系,包括HLE, FHL124, αTN4-1, N/N1003A 和 ARPE-19,已被证明对正常生理和发病机制的生化和分子分析有用。我们最近研究了这些细胞系表达全套的去甲酰化酶E1, E2 和 E3。在这项研究之后,我们检查了这些酶的定位,并确定了它们在这些主要眼细胞系中的差异定位模式。 方法: 在含有胎牛血清(FBS)或兔血清(RBS)和1%青霉素-链霉素的Dulbecco改良Eagle''s培养基(DMEM)中培养5个主要眼细胞系。用免疫组织化学方法测定了5个主要眼细胞系中3种主要苏门答腊酶的定位。这些图像是用Zeiss LSM 880共聚焦显微镜拍摄的。 结果: 结果表明:1)SUM酰化酶SAE1, UBC9 和 PIAS1分布在细胞核和细胞质中,在所有细胞系的细胞核和相邻的细胞器区都有较高的水平;2)SUM酰化酶UBA2高度集中在细胞质膜、细胞骨架和所有细胞系的细胞核;3)连接酶E3, RanBP2仅局限于细胞核内,分布均匀。 总结: 我们的研究结果首次建立了5种主要眼细胞株中3种苏门答腊酶的差异定位模式。我们在这些细胞系中建立了三种类型的苏门答腊酶的差异定位模式,有助于预测它们在视觉系统中的功能重要性。总之,我们的研究结果表明,这些细胞株可用于检测系统,以探讨苏门答腊作用介导眼部发育和发病机制的功能机制。
关键词: SAE1
Current Molecular Medicine
Title:Localization Patterns of Sumoylation Enzymes E1, E2 and E3 in Ocular Cell Lines Predict Their Functional Importance
Volume: 18 Issue: 8
关键词: SAE1
摘要: Purpose: It is well established now that protein sumoylation acts as an important regulatory mechanism mediating control of ocular development through regulation of multiple transcription factors. Yet the functional mechanisms of each factor modulated remain to be further explored using the available in vitro systems. In this regard, various ocular cell lines including HLE, FHL124, αTN4-1, N/N1003A and ARPE-19 have been demonstrated to be useful for biochemical and molecular analyses of normal physiology and pathogenesis. We have recently examined that these cell lines express a full set of sumoylation enzymes E1, E2 and E3. Following this study, here we have examined the localization of these enzymes and determined their differential localization patterns in these major ocular cell lines.
Methods: The 5 major ocular cell lines were cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing fetal bovine serum (FBS) or rabbit serum (RBS) and 1% Penicillin- Streptomycin. The localization of the 3 major sumoylation enzymes in the 5 major ocular cell lines were determined with immunohistochemistry. The images were captured with a Zeiss LSM 880 confocal microscope.
Results: we have obtained the following results: 1) The sumoylation enzymes SAE1, UBC9 and PIAS1 are distributed in both nucleus and cytoplasm, with a much higher level concentrated in the nucleus and the neighboring cellular organelle zone in all cell lines; 2) The sumoylation enzyme UBA2 was highly concentrated in both cytoplasm membrane, cytoskeleton and nucleus of all cell lines; 3) The ligase E3, RanBP2 was exclusively localized in the nucleus with homogeneous distribution.
Conclusions: Our results for the first time established the differential localization patterns of the three types of sumoylation enzymes in 5 major ocular cell lines. Our establishment of the differential localization patterns of the three types of sumoylation enzymes in these cell lines help to predict their functional importance of sumoylation in the vision system. Together, our results demonstrate that these cell lines can be used for assay systems to explore the functional mechanisms of sumoylation mediating ocular development and pathogenesis.
Export Options
About this article
Cite this article as:
Localization Patterns of Sumoylation Enzymes E1, E2 and E3 in Ocular Cell Lines Predict Their Functional Importance, Current Molecular Medicine 2018; 18 (8) . https://dx.doi.org/10.2174/1566524019666190112144436
DOI https://dx.doi.org/10.2174/1566524019666190112144436 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Proteomics Approach to Illustrate Drug Action Mechanisms
Current Drug Discovery Technologies Folate Tethered Gd2O3 Nanoparticles Exhibit Photoactive Antimicrobial Effects and pH Responsive Delivery of 5-fluorouracil into MCF-7 Cells
Drug Delivery Letters Chalcones in Cancer: Understanding their Role in Terms of QSAR
Current Medicinal Chemistry Circulating MicroRNAs as Biomarkers for Inflammatory Diseases
MicroRNA Development of Specific New ELISA for Bioanalysis of Cetuximab: A Monoclonal Antibody Used for Cancer Immunotherapy
Current Pharmaceutical Analysis Molecular Replacement in Cancer Therapy: Reversing Cancer Metabolic and Mitochondrial Dysfunction, Fatigue and the Adverse Effects of Cancer Therapy
Current Cancer Therapy Reviews Smart Polymers for Controlled Delivery of Proteins and Peptides: A Review of Patents
Recent Patents on Drug Delivery & Formulation Systemic and Biophase Bioavailability and Pharmacokinetics of Nanoparticulate Drug Delivery Systems
Current Drug Delivery Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy
Mini-Reviews in Medicinal Chemistry Research Progress on the Antitumor Effects of Rhein: Literature Review
Anti-Cancer Agents in Medicinal Chemistry Cytoplasmic CXCR4 High-Expression Exhibits Distinct Poor Clinicopathological Characteristics and Predicts Poor Prognosis in Triple-Negative Breast Cancer
Current Molecular Medicine Disulfide Linkage: A Potent Strategy in Tumor-Targeting Drug Discovery
Current Medicinal Chemistry Patent Selections:
Recent Patents on Medical Imaging ent-Abietane Lactones from Euphorbia
Mini-Reviews in Medicinal Chemistry Molecular Mechanisms of Tumor Invasion and Metastasis: An Integrated View
Current Molecular Medicine Mechanical Imaging - a Technology for 3-D Visualization and Characterization of Soft Tissue Abnormalities: A Review
Current Medical Imaging The Chick Embryo Chorioallantoic Membrane as a Model for in vivo Research on Anti-Angiogenesis
Current Pharmaceutical Biotechnology Erythropoietin in Cancer: An Update
Current Molecular Medicine Tyrosine Kinases as Molecular Targets to Inhibit Cancer Progression and Metastasis
Current Pharmaceutical Design Tumor Stem Cell Niches: A New Functional Framework for the Action of Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery